Biography
Prof Carolyn Lam is a Senior Consultant Cardiologist and Director of Women’s Heart Health at the National Heart Centre Singapore, where she pioneered the country’s first Women’s Heart Clinic. Internationally recognised for her expertise in heart failure with preserved ejection fraction (HFpEF), Prof Lam has played a key role in landmark clinical trials including PARAGON-HF, EMPEROR-Preserved, DELIVER and FINEARTS-HF.
Her work helped establish the first FDA-approved treatment for HFpEF and the first trial to demonstrate robust clinical benefit in this patient population. A prolific researcher, Prof Lam has authored over 700 peer-reviewed publications in top journals such as New England Journal of Medicine, Lancet, JAMA, Circulation and European Heart Journal. She was named a Clarivate Highly Cited Researcher in Clinical Medicine from 2021 to 2024.
Prof Lam is also a deputy editor of the Journal of the American College of Cardiology (JACC) and served on the 2021–2022 ESC Heart Failure Guidelines Task Force. In digital health, she co-founded Us2.ai, a MedTech startup using artificial intelligence to automate echocardiography and improve access to heart disease diagnosis worldwide.
Media
Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain
Jeffrey Weitz, Carolyn Lam, Davide Capodanno, et al
Carolyn Lam, Jeffrey Weitz, Sneha Shah Jain, et al
Video Series
Carolyn Lam, Carys Barton, Stephen J Greene, et al
Scott Solomon, Shelley Zieroth, Carolyn Lam, et al
Muthiah Vaduganathan, Carolyn Lam,
Carolyn Lam, Scott Solomon, John JV McMurray, et al
Shelley Zieroth, Javed Butler, Carolyn Lam
Shelley Zieroth, Andrew JS Coats, Javed Butler, et al
Jack Tan Wei Chieh, Carolyn Lam, Daniel Yeo, et al
Carolyn Lam, Wan Azman Wan Ahmad, Azmee Mohd Ghazi, et al
Andrew JS Coats, Piotr Ponikowski, Stefan Anker, et al
Andrew JS Coats, Carolyn Lam, Felipe Martínez, et al
Articles by Carolyn Lam, Professor and Senior Consultant Cardiologist
Carolyn Lam,
Published:
Citation: Cardiac Failure Review 2015;1(1 Suppl 1):3-4.